In conclusion, although dietary CL treatment of LDLR-deficient mice with established atherosclerosis reduced adiposity and plasma lipid concentrations, these changes did not translate into reduced plaque burden in our experimental regimen. This evidence concerns the gene LDLR and atherosclerosis.